Empatica

Our new CE-certified Parkinson’s monitoring solution is here: EmbraceMini, a companion app & the Care Portal, powered by PKG algorithms for continuous, real-world insights and more personalized care. bit.ly/3NM4pZ4 #ParkinsonsDisease #WearableTech #MovementDisorders

The Empatica team is heading to the World Parkinson Congress in Phoenix. Looking forward to conversations that bring together researchers, clinicians, caregivers, and people living with #Parkinsons, because meaningful progress starts by listening. #WPC2026 #ParkinsonsDisease

@sir4K_zen @DatalandMuseum Thank you, we can't wait for the grand opening!

@empatica @DatalandMuseum Ingenious blend of art and data, congrats on the Grand LA launch

We are excited to announce that @DatalandMuseum opens June 20 at The Grand LA in DTLA! We're proud to help power the technologies behind this groundbreaking museum, connecting art, architecture, and the audience within a building that dreams and remembers. Machine Dreams: Rainforest, #DATALAND’s inaugural exhibition, is an omni-sensory experience that uses data to deepen the connection between audience, machine intelligence, and the natural world. We created a custom consumer version of EmbracePlus, our FDA-cleared wearable medical device, with adapted software and algorithms that enable real-time data streaming throughout the experience. The installation evolves in response to the audience’s collective emotional state, creating a living dialogue between people and art.

Join Empatica’s Chase Babcock and Prof. Francesca Morgante to explore how continuous monitoring, wearable technology, and digital biomarkers are helping improve insights into #Parkinsons symptoms and ‘OFF’ periods beyond the clinic. 🔗Register: bit.ly/3R7KWDU

Does wearable monitoring add burden or streamline care? Prof. K. Ray Chaudhuri shared how objective data can reduce uncertainty and improve decisions. A PKG cost-effectiveness study shows fewer hospital visits and ~£14K savings per patient. 🎥bit.ly/4dw5nTs #Parkinsons

We’re recruiting participants for a usability study on a new medical wearable and companion mobile app designed to support Parkinson’s monitoring. 🎁 Thank you gift Participants will receive a $200 gift card for their time. Learn more and apply bit.ly/4u1pPBH #Wearables #WearableTech #WearableTechnology

New @GreenJournal study shows how #SUDEP awareness shapes parental grief: lack of knowledge fuels guilt, while awareness can help families process loss. We’ll be joined by two of the study’s authors to discuss why breaking the silence matters. Register ➡️bit.ly/4eQz0A4 #SUDEPAwareness #EpilepsyAwareness

As #ParkinsonsAwarenessMonth ends, the work continues. Daily symptoms often happen outside the clinic. Continuous monitoring can bring clarity between visits, helping inform better treatment and more personalized care. #Parkinsons #DigitalHealth

Hearing loss is linked to cognitive decline & dementia. New research with @EriksholmRC published in @Sciencedirect shows the EmbracePlus can predict listening effort using biomarkers, unlocking real-world endpoints in #aging & #neuroresearch bit.ly/4unh4Sh

#RCTs are essential for evaluating new treatments, yet ~20–25% are discontinued early (@JClinEpi). We surveyed researchers using EmbracePlus 👉92% achieved ≥75% completion. Better participant experience and onboarding can support sustained engagement. 🔗 bit.ly/48nHquO

Join our webinar on SUDEP (Sudden Unexpected Death in Epilepsy) to explore new research published in @GreenJournal on awareness, grief, and communication. Hear from leading experts and our Chief Scientist, @RosalindPicard. 👉bit.ly/4945lj0 #Epilepsy #SUDEP #Neurology

As #ParkinsonsAwarenessMonth continues, a key gap remains: care decisions rely on snapshots, while symptoms fluctuate at home. A 12-month PKG analysis published in @MDPIOpenAccess shows it can better inform treatment and reduce caregiver burden➡️ bit.ly/4mtFPcy #PD

Participant compliance has long been seen as a risk, which may be driving larger, costlier trials. We surveyed 84 clients, and 90% reported ≥80% compliance. 🔗Read more: bit.ly/4e968CH #DigitalHealth #WearableTech

We’ll be at the American Academy of Neurology Annual Meeting in Chicago! Visit us at booth #4432 to see EpiMonitor and our CE-certified Parkinson’s solution in action, and learn how we’re advancing neurology care and research with continuous, real-world data. @AANmember #AAN2026

Optimizing #Parkinsons care means linking objective data to real outcomes. PKG-guided treatment improved quality of life in patients with poorer baseline scores and reduced caregiver burden in a 12-month study. 🎥 Watch the full webinar: bit.ly/4v9bhRr #DigitalHealth

📣 EpiMonitor is now available in Canada, Australia & New Zealand! Following key regulatory milestones, including ARTG listing and a Health Canada license, we’re expanding access to our medical-grade epilepsy monitoring worldwide. 👉 bit.ly/4dDYfFp #SeizureMonitoring

New validation shows PKG algorithms deliver consistent results on EmbracePlus & EmbraceMini vs the PKG Watch. Strong agreement across bradykinesia, dyskinesia & tremor supports reliable Parkinson’s monitoring in research & real-world use. 📄bit.ly/481Enbp

#BreastCancer care brings significant stress, yet it’s rarely measured objectively. The PEXRT study uses EmbracePlus to capture real-time stress during CT & LINAC sessions, unobtrusively and alongside PROs, offering a more complete picture of patient experience. Read more➡️ bit.ly/4dJvrem #Oncology #WearableTech